Enhanced expression of a new class of liver-enriched b-Zip transcription factors, hepatocarcinogenesis-related transcription factor, in hepatocellular carcinomas of rats and humans

Cell Growth and Differentiation

Volumn 9, Issue 4, 1998, Pages 337-344

  Kishimoto, Toshihiko ^a,b   Kokura, Kenji ^a   Ohkawa, Noriaki ^a   Makino, Yasutaka ^a   Yoshida, Mitsuaki ^c   Hirohashi, Setsuo ^d   Niwa, Shin Ichiro ^b   Muramatsu, Masami ^e   Tamura, Taka Aki ^a,f  

^a CHIBA UNIVERSITY   (Japan)

^b SUMITOMO ELECTRIC INDUSTRIES LTD   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e SAITAMA MEDICAL UNIVERSITY   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER REGENERATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

EID: 0031868427     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Beasley, R. P., Lin, C-C., Hwang, L-Y., and Chien, C. S. Hepatocellular carcinoma and hepatitis B virus. Lancet, 2: 1129-1133, 1981.
2. Bhandari, B. N., and Wright, T. L. Hepatitis C: an overview. Annu. Rev. Med., 46: 309-317, 1995.
3. Bukh, J., Miller, R. H., Kew, M. C., and Purcell, R. H. Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 90: 1848-1851, 1993.
4. Caselmann, W. H. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. J. Hepatol., 22: 34-37, 1995.
5. Kim, C-M., Koike, K., Saito, I., Miyamura, T., and Jay, G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (Lond.), 351: 317-320, 1991.
6. Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., and Cerutti, P. Geographic variation of p53 mutational profile in nonmalignant human liver. Science (Washington DC), 264: 1317-1319, 1994.
7. Aguilar, F., Hussain, S. P., and Cerutti, P. Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl. Acad. Sci. USA, 90: 8586-8590, 1993.
8. Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenaga, M., Imura, H., and Ishizaki, K. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res., 53: 368-372, 1993.
9. Choi, E. K., Uyeno, S., Nishida, N., Okamoto, T., Fujimura, S., Aoki, Y., Nata, M., Sagisaka, K., Fukuda, Y., Nakao, K., Yoshimoto, T., Kim, Y. S., and Ono, T. Alterations of c-fos gene methylation in the process of aging and tumorigenesis in human liver. Mutat. Res., 354: 123-128, 1996.
10. Kataoka, K., Noda, M., and Nishizawa, M. Naf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol. Cell. Biol., 14: 700-712, 1994.
11. Kerppola, T. K., and Curran, T. A conserved region adjacent to the basic domain is required for recognition of and extended DNA binding site by Maf/Nrl family proteins. Oncogene, 9: 3149-3158, 1994.
12. Etiemble, J., Degott, C., Renard, C. A., Fourel, G., Shamoon, S., Vitvitski-Trepo, L., Hsu, T. Y., Tiollais, P., Babinet, C., and Buendia, M. A. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion. Oncogene, 9: 727-737, 1994.
13. Hansen, L. J., Tennant, B. C., Seeger, C., and Ganem, D. Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses. Mol. Cell. Biol., 13: 659-667, 1993.
14. Miller, R. T., Glover, S. E., Stewart, W. S., Corton, J. C., Popp, J. A., and Cattley, R. C. Effect on the expression of c-met, c-myc and PPAR-α in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,463. Carcinogenesis (Lond.), 17: 1337-1341, 1996.
15. Herschman, H. R. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem., 60: 281-319, 1991.
16. Kuo, C. J., Conley, P. B., Hsieh, C-L., Francke, U., and Crabtree, S. Molecular cloning, functional expression and chromosomal localization of mouse hepatocyte nuclear factor 1. Proc. Natl. Acad. Sci. USA, 87: 9838-9842, 1990.
17. Lai, E., Prezioso, V. R., Smith, E., Litvin, O., Costa, R. H., and Darnell, J. E. HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev., 4: 1427-1436, 1990.
18. McKnight, S. L., Lane, M. D., and Gluecksohn-Waelsch, S. Is CAAT/ enhancer-binding protein a central regulator of energy metabolism. Genes Dev., 3: 2021-2024, 1989.
19. Umek, R. M., Fiedman, A. D., and McKnight, S. L. CCAAT-enhancer binding protein: a component of a differentiation switch. Science (Washington DC), 251: 288-292, 1991.
20. Paonessa, G., Gounari, F., Frank, R., and Cortese, R. Purification of a NF-1 like DNA-binding protein from rat liver and cloning of the corresponding cDNA. EMBO J., 7: 3115-3123, 1988.
21. Lichtsteiner, S., Wuarin, J., and Schibier, U. The interplay of DNA-binding proteins on the promoter of the mouse albumin gene. Cell, 51: 963-973, 1987.
22. Hunger, S. P., Ohyashiki, K., Toyama, K., and Cleary, M. L. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev., 6: 1608-1620, 1992.
23. Hsu, J. C., Laz, T., Mohn, K. L., and Taub, R. Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver. Proc. Natl. Acad. Sci. USA, 88: 3511-3515, 1991.
24. Kishimoto, T., Kokura, K., Kumagai, Y., Makino, Y., and Tamura, T. HTF. A b-Zip transcription factor that is closely related to the human XBP/TREB5 and is activated by hepatocellular carcinoma in rats. Biochem. Biophys. Res. Commun., 223: 746-751, 1996.
25. Liou, H-C., Boothby, M. R., Finn, P. W., Davidon, R., Nabavi, N., Zeleznik-Le, N. J., Ting, J. P-Y., and Glimcher, L. H. A new member of the leucine zipper class of proteins that binds to the HLA DRα promoter. Science (Washington DC), 247: 1581-1584, 1990.
26. Yoshimura, T., Fujisawa, J., and Yoshida, M. Multiple cDNA clones encoding nuclear proteins that bind to the tax-dependent enhancer of HTLV-1: all contain a leucine zipper structure and basic amino acid domain. EMBO J., 9: 2537-2542, 1990.
27. Nishizawa, M., Kataoka, K., Goto, N., Fujisawa, K. T., and Sawai, S. v-maf, a viral oncogene that encodes a "leucine-zipper" motif. Proc. Natl. Acad. Sci. USA, 86: 7711-7715, 1989.
28. Iyer, S. V., Davis, D. L., Seal, S. N., and Burch, B. E. Chicken vitellogenin gene-binding protein, a leucine zipper transcription factor that binds to an important control element in the chicken vitellogenin II promoter, is related to rat DBP. Mol. Cell. Biol., 11: 4863-4875, 1991.
29. Montesano, R., Matsumoto, K., Nakamura, T., and Orci, L. Identification of a fibroblast-derived epithelial morphogene as hepatocyte growth factor. Cell, 67: 901-908, 1991.
30. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., and Shimizu, S. Molecular cloning and expression of human hepatocyte growth factor. Nature (Lond.), 342: 440-443, 1989.
31. Liou, H-C., Eddy, R., Shows, T., Lisowska-Grospierre, B., Grisculli, C., Doyle, C., Mannhalter, J., Eibl, M., and Glimcher, L. H. An HLA-DRα promoter DNA-binding protein is expressed ubiquitously and maps to human chromosomes 22 and 5. Immunogenetics, 34: 286-292, 1991.
32. Ponath, P. D., Fass, D., Liou, H-C., Glimcher, L. H., and Strominger, J. L. The regulatory gene, hXBP-1, and its target, HLA-DRA, utilize both common and distinct regulatory elements and protein complexes. J. Biol. Chem., 260: 17074-17082, 1993.
33. Ono, S. J., Liou, H-C., Davidon, R., and Strominger, J. L. Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. Proc. Natl. Acad. Sci. USA, 88: 4309-4312, 1991.
34. Solt, D., and Farber, E. New principle for the analysis of chemical carcinogenesis. Nature (Lond.), 263: 701-703, 1976.
35. Kishimoto, T., Kokura, K., Nakadai, T., Miyazawa, Y., Wakamatsu, T., Makino, Y., Nakamura, T., Hara, E., Oda, K., Muramatsu, M., and Tamura, Y. Overexpression of cysteine sulfinic acid decarboxylase stimulated by hepatocarcinogenesis results in autoantibody production in rats. Cancer Res., 56: 5230-5237, 1996.
36. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
37. Tamura, T., Ohya, Y., Miura, M., Aoyama, A., Inoue, T., and Mikoshiba, K. Preparation of large amounts of transcription-competent nuclear extracts from mouse brain. Technique (Phila.), 1: 33-36, 1989.
38. Peterson, M. G., Tanese, N., Pugh, B. G., and Tjian R. Functional domains and upstream activation properties of cloned human TATA binding protein. Science (Washington DC), 248: 1625-1630, 1990.
39. Li, Y., and Benezra, R. Identification of human mitotic checkpoint gene: hsMAD2. Science (Washington DC), 274: 246-248, 1996.
40. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.